Cencora 

$281.43
351
-$0.31-0.11% 今天

統計

當日最高
282.12
當日最低
274.71
52週高點
377.54
52週低點
244.82
成交量
4,714,906
平均成交量
-
市值
54.75B
本益比
21.6
股息殖利率
0.85%
股息
2.4

即將到來

股息

0.85%股息殖利率
Jun 26
$0.60
Mar 26
$0.60
Dec 25
$0.60
Sep 25
$0.55
Jun 25
$0.55
10年成長
5.65%
5年成長
6.16%
3年成長
6.89%
1年成長
6.67%

財報

5Aug預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
3.5
3.94
4.38
4.82
預期EPS
4.347912
實際EPS
不適用

財務

0.48%利潤率
有盈利
2020
2021
2022
2023
2024
2025
642.67B營收
3.11B淨利

分析師評級

370.60平均目標價
最高預估為 440.00。
來自過去6個月內的 11 則評分。這不是投資建議。
買入
82%
持有
18%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 COR 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Show more...
執行長
Dr. Robert P. Mauch Ph.D., PharmD
員工
47000
國家
美國
ISIN
US03073E1055

上市

0 Comments

分享你的想法

FAQ

Cencora 今天的股價是多少?
COR 目前價格為 $281.43 USD,過去 24 小時下跌了 -0.11%。在圖表上更密切關注 Cencora 股票的表現。
Cencora 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Cencora 的股票以代號 COR 進行交易。
Cencora 的股價在上漲嗎?
COR 股票較上週上漲 +2.68%,本月上漲 +9.2%,但過去一年 Cencora 下跌 -4.77%。
Cencora 的市值是多少?
今天 Cencora 的市值為 54.75B
Cencora 下一次財報日期是什麼時候?
Cencora 將於 August 05, 2026 公布下一次財報。
Cencora 上一季度的財報如何?
COR 上一季度的財報為每股 4.75 USD,預估為 4.82 USD,帶來 -1.42% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Cencora 去年的營收是多少?
Cencora 去年的營收為 642.67BUSD。
Cencora 去年的淨利是多少?
COR 去年的淨收益為 3.11BUSD。
Cencora 會發放股息嗎?
是的,COR 的股息每 每季 發放一次。每股最新股息為 0.6 USD。截至今日,股息殖利率(FWD)% 為 0.85%。
Cencora 有多少名員工?
截至 June 15, 2026,公司共有 47,000 名員工。
Cencora 位於哪個產業?
Cencora從事於Health & Wellness產業。
Cencora 何時完成拆股?
Cencora 上次拆股發生於 June 16, 2009,比例為 2:1。
Cencora 的總部在哪裡?
Cencora 的總部位於 美國 的 Conshohocken。